CARGO Therapeutics, Inc. (CRGX)
NASDAQ: CRGX · Real-Time Price · USD
16.23
+0.50 (3.18%)
At close: Nov 22, 2024, 4:00 PM
15.95
-0.28 (-1.73%)
After-hours: Nov 22, 2024, 4:00 PM EST
CARGO Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for CARGO Therapeutics stock have an average target of 30.33, with a low estimate of 23 and a high estimate of 34. The average target predicts an increase of 86.88% from the current stock price of 16.23.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CRGX stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $33 | Strong Buy | Reiterates | $33 | +103.33% | Nov 15, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $28 | Strong Buy | Maintains | $28 | +72.52% | Nov 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $37 → $34 | Buy | Maintains | $37 → $34 | +109.49% | Aug 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $33 | Strong Buy | Reiterates | $33 | +103.33% | Aug 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $33 | Strong Buy | Initiates | $33 | +103.33% | Jul 22, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
850.00K
EPS This Year
-4.35
from -16.53
EPS Next Year
-4.75
from -4.35
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 5.3M | 192.7M | ||
| Avg | n/a | 849,997 | 52.5M | ||
| Low | n/a | n/a | 6.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 22,569.5% | ||
| Avg | - | - | 6,070.6% | ||
| Low | - | - | 707.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -4.07 | -3.61 | -3.54 |
| Avg | -4.35 | -4.75 | -4.18 |
| Low | -5.20 | -6.04 | -5.00 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.